Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry

Dauriz, Marco, Targher, Giovanni, Laroche, Cécile, Temporelli, Pier Luigi, Ferrari, Roberto, Anker, Stephan, Coats, Andrew, Filippatos, Gerasimos +6 more·2017·Diabetes Care

Cited by (139)

Items 101–139 of 139

  1. Hydration status in patients hospitalized with acute decompensated heart failure depending on the severity of glucose metabolism disorder
    Veronika V. Tolkacheva, M. L. Diane, Nutsiko Ivanovna Khutsishvili, Flora Elisa Cabello Montoya, Ivan Sergeevich Nazarov, Ilya Pavlovich Smirnov, Svyatoslav A. Galochkin, Zhanna D. Kobalava · 2024 · Bulletin of Siberian Medicine
  2. Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
    Giulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, Tommaso Bucci, Marco Proietti, Min Qian, Yineng Chen, John L.P. Thompson, Shunichi Homma, Gregory Y.H. Lip et al. · 2024 · Internal and Emergency Medicine
  3. Type 2 diabetes increases the risk of mortality and cardiovascular events in ischemic HFmrEF patients: a retrospective cohort study
    Zhican Liu, Hailong Hu, Jianping Zeng, Mingyan Jiang · 2025 · Diabetology & Metabolic Syndrome
  4. Lower limb oedema in diabetes
    Rowan Hillson · 2017 · Practical Diabetes
  5. Tratamiento de la diabetes en el paciente con insuficiencia cardiaca: Más allá de la hemoglobina glicosilada
    Gilberto A. Castillo, Enrique Morales-Villegas · 2020 · Revista Colombiana de Cardiología
  6. Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?
    Ariana P. Vargas-Delgado, Juan Antonio Requena Ibáñez, Carlos G. Santos‐Gallego, Juan J. Badimón · 2021 · Clínica e Investigación en Arteriosclerosis (English Edition)
  7. Patients characteristics and prognostic implications of type 2 diabetes mellitus in heart failure with preserved, mid-rang reduced and reduced ejection fraction
    Marija Mrvošević, Marija M. Polovina · 2021 · Medicinski podmladak
  8. A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection Fraction
    Gladys I. Palaguachi, William H. Frishman · 2021 · Cardiology in Review
  9. Glifozinas en el tratamiento de la diabetes tipo 2: más allá de los beneficios en el control metabólico
    Cristopher Aarón Giler Avila, Eduardo Josué Milian Hernández · 2023 · Anatomía Digital
  10. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
    Giuseppe M.C. Rosano, Piotr P. Ponikowski, Cristiana Vitale, Stefan D. Anker, Javed Butler, Vincent Fabien, Gerasimos S Filippatos, Bridget‐Anne Kirwan, Iain C. Macdougall, Marco Metra et al. · 2023 · Cardiovascular Diabetology
  11. Diabetes Advances Cardiomyocyte Senescence through miR-103a-3p/Rnd3/STAT3 Signaling
    Linxu Wu, Xinglin Zhu, Cai Luo, Yan Chen, Yin Liu, Yangyang Zhao, Shan-Shan Pan, Kaijia Shi, Jingci Xing, Xuebin Lin et al. · 2024 · medRxiv
  12. Decoding the inflammatory–metabolic code: machine learning potential for outcome prediction in heart failure with diabetes
    Luca Monzo, Nicolas Girerd · 2025 · International Journal of Cardiology
  13. Diabetes mellitus and heart failure: insights from a toxic relationship
    Moritz Hundertmark, Eleanor C. Wicks · 2018 · Practical Diabetes
  14. Mechanisms of exercise intolerance in chronic heart failureand type 2 diabetes mellitus
    Jack O. Garnham · 2018
  15. Heart Failure and Metabolic Factors
    Peter M. Nilsson, John Molvin, Martin Magnusson · 2019 · Updates in hypertension and cardiovascular protection
  16. The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
    M Melville · 2019 · British Journal of Cardiac Nursing
  17. Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control
    Petar M Seferovic, Pardeep S. Jhund · 2019 · European Heart Journal Supplements
  18. Аналіз віддалених результатів комплексного лікування ішемічної хвороби серця упацієнтів із предіабетом та явним цукровим діабетом
    Yana Yu. Dzhun, G.B. Mankovsky, Nadiya M. Rudenko · 2021 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  19. Heart failure with reduced, mid-range and preserved left ventricular ejection fraction in Chinese with type 2 diabetes: risk factors and prognosis from time of first index hospitalization
    Andrea O. Y. Luk, Xinge Zhang, Erik Fung, Hongjiang Wu, Eric S. H. Lau, Aimin Yang, Elaine Chow, Alice P.S. Kong, Ronald C.W., Juliana C.N. Chan · 2021 · Research Square
  20. The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
    Martin Mellville · 2019 · Journal of Prescribing Practice
  21. Impact of sex and diabetes in patients with heart failure with mildly reduced ejection fraction
    Derek Pok Him Lee · 2022 · Annals of the Academy of Medicine Singapore
  22. Herzinsuffizienz bei Menschen mit Diabetes mellitus
    Katharina S. Schütt · 2022 · Diabetes aktuell
  23. THE EFFECTIVENESS OF A DIABETES MELLITUS PICTORIAL DIARY HANDBOOK PROGRAM FOR MIDDLE AGED AND ELDERLY TYPE 2 DIABETES MELLITUS PATIENTS: A QUASI EXPERIMENTAL STUDY AT HEALTH PROMOTING HOSPITALS TALADNOI SARABURI PROVINCE THAILAND
    Rapat Eknithiset · 2017
  24. Efficiency and safety of adding semaglutide for the management of patients with type 2 diabetes and heart failure in real-world clinical practice
    Martina God, Marin Viđak, Ivana Jurin, Šime Manola · 2023 · Cardiologia Croatica
  25. Diabetes, prediabetes, and heart failure
    Giuseppe M.C. Rosano, Javed Butler, Petar M Seferovic, Jelena P. Seferović, Francesco Cosentino · 2023 · Oxford University Press eBooks
  26. Heart Failure and Diabetes
    Ambarish Pandey, Kershaw V. Patel, Subodh Verma · 2024
  27. Herzinsuffizienz bei Patienten mit Diabetes mellitus
    Katharina S. Schütt, Amin Polzin · 2024 · Aktuelle Kardiologie
  28. Beyond boundaries: exploring the latest guidelines for diabetes and cardiovascular health
    Victora Ruszala, Rhys Williams · 2024 · British Journal of Cardiac Nursing
  29. Beyond boundaries: exploring the latest guidelines for diabetes and cardiovascular health
    Victoria Ruszala, Rhys Williams · 2025 · Practice Nursing
  30. DIABETES MELLITUS COMO FATOR DE RISCO PARA DOENÇAS CARDIOVASCULARES: CONTRIBUIÇÃO DA ENFERMAGEM
    Germano de Sousa, Yasmin De Santana Costa, Kamilla Fernanda Sousa, Giovanna Avancini Tavares, Reyna Belem Mamani Paredes, Kathleen Melchior Altruda, Silvana Flora de Melo, J Costa · 2025 · Revista Foco
  31. Additional file 1 of Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
    Rosano, Giuseppe, Ponikowski, Piotr, Cristiana Vitale, Stefan D. Anker, Javed Butler, Vincent Fabien, Filippatos, Gerasimos, Bridget‐Anne Kirwan, Iain C. Macdougall, Metra, Marco et al. · 2023 · Figshare
  32. Additional file 3 of Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung, Yuan Lin, Lin, Ming-Shyan, Tsai, Tzu-Hsien, Yang, Ning-I, Wang, Chao-Yung, Hsieh, I-Chang, Hung, Ming-Jui, Chen, Tien-Hsing · 2023 · Figshare
  33. Additional file 1 of Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung, Yuan Lin, Lin, Ming-Shyan, Tsai, Tzu-Hsien, Yang, Ning-I, Wang, Chao-Yung, Hsieh, I-Chang, Hung, Ming-Jui, Chen, Tien-Hsing · 2023 · Figshare
  34. Additional file 2 of Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung, Yuan Lin, Lin, Ming-Shyan, Tsai, Tzu-Hsien, Yang, Ning-I, Wang, Chao-Yung, Hsieh, I-Chang, Hung, Ming-Jui, Chen, Tien-Hsing · 2023 · Figshare
  35. The WATCH-DM integer-based risk score identifies risk of all-cause mortality in patients with type 2 diabetes: a retrospective cohort study
    Chin‐Sung Kuo, Nai-Rong Kuo, Po‐Hsun Huang, Chii‐Min Hwu · 2026 · Therapeutic Advances in Endocrinology and Metabolism
  36. Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study
    Kazuya Hiura, Hirotaka Masuda, Masayuki Sakunami, Miki Yamashita · 2026 · Journal of Diabetes Investigation
  37. A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation
    Zhe Zhang, Dengao Li, Jumin Zhao, Huiting Ma, Fang Wang, Qi Hao · 2026 · Medicine
  38. Heart failure hospitalization in patients with and without type 2 diabetes: A population-based retrospective cohort study
    Allison K. Shay, Wei Tao, Soumya Patnaik, Delaney K. Sullivan, Angelo Nascimbene, Xueying Wang, Joseph B. McCormick, Hulin Wu · 2026 · PLoS ONE
  39. Diretriz Brasileira de Insuficiência Cardíaca – 2026
    Marcus Vinı́cius Simões, Lídia Zytynski Moura, Sílvia Marinho Martins, Ricardo Mourilhe‐Rocha, Luiz Cláudio Danzmann, José Albuquerque de Figueiredo Neto, Fabiana G. Marcondes‐Braga, Múcio Tavares de Oliveira, Denílson Campos de Albuquerque, Aguinaldo Figueiredo Freitas et al. · 2026 · Arquivos Brasileiros de Cardiologia